Acorn BioLabs | Drew Taylor, CEO

Acorn is developing a non-invasive cryopreservation solution for the preservation of healthy follicle cells for use in cellular treatments.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Drew Taylor
Drew Taylor
CEO, Acorn BioLabs